These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31139876)

  • 21. The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder.
    Masi A; Glozier N; Dale R; Guastella AJ
    Neurosci Bull; 2017 Apr; 33(2):194-204. PubMed ID: 28238116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A potential mechanistic role for neuroinflammation in reward processing impairments in autism spectrum disorder.
    Greene RK; Walsh E; Mosner MG; Dichter GS
    Biol Psychol; 2019 Mar; 142():1-12. PubMed ID: 30552950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD).
    Liu H; Talalay P; Fahey JW
    CNS Neurol Disord Drug Targets; 2016; 15(5):602-13. PubMed ID: 27071792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune Endophenotypes in Children With Autism Spectrum Disorder.
    Careaga M; Rogers S; Hansen RL; Amaral DG; Van de Water J; Ashwood P
    Biol Psychiatry; 2017 Mar; 81(5):434-441. PubMed ID: 26493496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder.
    Gevezova M; Sarafian V; Anderson G; Maes M
    CNS Neurol Disord Drug Targets; 2020; 19(5):320-333. PubMed ID: 32600237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation.
    Melamed IR; Heffron M; Testori A; Lipe K
    Autism Res; 2018 Mar; 11(3):421-433. PubMed ID: 29427532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel concept of immunological and allergy interactions in autism spectrum disorders: Molecular, anti-inflammatory effect of osthole.
    Kordulewska NK; Kostyra E; Chwała B; Moszyńska M; Cieślińska A; Fiedorowicz E; Jarmołowska B
    Int Immunopharmacol; 2019 Jul; 72():1-11. PubMed ID: 30953868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic inflammation in asocial BTBR T
    Nadeem A; Ahmad SF; El-Sherbeeny AM; Al-Harbi NO; Bakheet SA; Attia SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():8-17. PubMed ID: 29287831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convergence of Sex Differences and the Neuroimmune System in Autism Spectrum Disorder.
    McCarthy MM; Wright CL
    Biol Psychiatry; 2017 Mar; 81(5):402-410. PubMed ID: 27871670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin mediated immunoregulation and neural functions: Complicity in the aetiology of autism spectrum disorders.
    Jaiswal P; Mohanakumar KP; Rajamma U
    Neurosci Biobehav Rev; 2015 Aug; 55():413-31. PubMed ID: 26021727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTSD and autism spectrum disorder: Co-morbidity, gaps in research, and potential shared mechanisms.
    Haruvi-Lamdan N; Horesh D; Golan O
    Psychol Trauma; 2018 May; 10(3):290-299. PubMed ID: 28726442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral inhibition and activation as a modifier process in autism spectrum disorder: Examination of self-reported BIS/BAS and alpha EEG asymmetry.
    Schiltz HK; McVey AJ; Barrington A; Haendel AD; Dolan BK; Willar KS; Pleiss S; Karst JS; Vogt E; Murphy CC; Gonring K; Van Hecke AV
    Autism Res; 2018 Dec; 11(12):1653-1666. PubMed ID: 30475457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The positive association between elevated blood lead levels and brain-specific autoantibodies in autistic children from low lead-polluted areas.
    Mostafa GA; Bjørklund G; Urbina MA; Al-Ayadhi LY
    Metab Brain Dis; 2016 Oct; 31(5):1047-54. PubMed ID: 27250967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral phenotypes and neurobiological mechanisms in the Shank1 mouse model for autism spectrum disorder: A translational perspective.
    Sungur AÖ; Schwarting RKW; Wöhr M
    Behav Brain Res; 2018 Oct; 352():46-61. PubMed ID: 28963042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune dysfunction and neuroinflammation in autism spectrum disorder.
    Bjorklund G; Saad K; Chirumbolo S; Kern JK; Geier DA; Geier MR; Urbina MA
    Acta Neurobiol Exp (Wars); 2016; 76(4):257-268. PubMed ID: 28094817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.
    Rose S; Niyazov DM; Rossignol DA; Goldenthal M; Kahler SG; Frye RE
    Mol Diagn Ther; 2018 Oct; 22(5):571-593. PubMed ID: 30039193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emotion regulation in autism spectrum disorder: Where we are and where we need to go.
    Cai RY; Richdale AL; Uljarević M; Dissanayake C; Samson AC
    Autism Res; 2018 Jul; 11(7):962-978. PubMed ID: 29979494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal inflammatory pain and systemic inflammatory responses as possible environmental factors in the development of autism spectrum disorder of juvenile rats.
    Lee JH; Espinera AR; Chen D; Choi KE; Caslin AY; Won S; Pecoraro V; Xu GY; Wei L; Yu SP
    J Neuroinflammation; 2016 May; 13(1):109. PubMed ID: 27184741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflammation in autism spectrum disorders: Exercise as a "pharmacological" tool.
    Toscano CVA; Barros L; Lima AB; Nunes T; Carvalho HM; Gaspar JM
    Neurosci Biobehav Rev; 2021 Oct; 129():63-74. PubMed ID: 34310976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment.
    Ebrahimi Meimand S; Rostam-Abadi Y; Rezaei N
    Expert Rev Clin Immunol; 2021 Jan; 17(1):27-35. PubMed ID: 33191807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.